NCT07301021 (VPIMMA) is a clinical trial in Velopharyngeal Insufficiency, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Who is sponsoring NCT07301021?

NCT07301021 is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

What condition does NCT07301021 study?

NCT07301021 studies Velopharyngeal Insufficiency, Swallowing, Nasality, Speech.

Is NCT07301021 still recruiting?

NCT07301021 is currently not yet recruiting. Last updated 20 March 2026.

Last reviewed 2026-03-20 · How we verify

NCT07301021: VPIMMA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Velopharyngeal Insufficiency After Maxillomandibular Advancement Osteotomy in Obstructive Sleep Apnea Patients

Not yet recruiting Last updated 20 March 2026

What this trial tests

trial in Velopharyngeal Insufficiency in 28 participants. Not yet recruiting.

Timeline

1 May 2026

Primary endpoint
1 December 2027

1 December 2027

Quick facts

Lead sponsor	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	28
Start date	1 May 2026
Primary completion	1 December 2027
Estimated completion	1 December 2027
Sites	1 location across Netherlands

Conditions studied

Velopharyngeal Insufficiency — all drugs for Velopharyngeal Insufficiency →
Swallowing — all drugs for Swallowing →
Nasality — all drugs for Nasality →
Speech — all drugs for Speech →

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) — full company profile →

Who can join

18 and older, any sex, with Velopharyngeal Insufficiency or Swallowing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to gain insight into the development of velopharyngeal insufficiency (VPI) in patients who have undergone maxillomandibular advancement osteotomy (MMA) as a treatment for obstructive sleep apnea syndrome (OSAS). A speech therapist evaluates nasality, speech, and swallowing before and after the surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Velopharyngeal Insufficiency

Currently open trials in the same condition.

NCT07264036 — Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study · NA · recruiting

Other Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) trials

Trials by the same sponsor.

NCT07359482 — sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19 · Phase 3 · not yet recruiting
NCT07457957 — Effectiveness of an mHealth Innovation on the Impact of Menstrual Complaints in Adolescents · NA · not yet recruiting
NCT06909045 — Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease · NA · recruiting
NCT07316127 — Immunoadsorption in Autoimmune Long COVID · Phase 2 · recruiting
NCT07231835 — Registry of Coronary Disease Outcomes Revascularizing With Drug-Coated Balloons · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07301021 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Last refreshed: 20 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07301021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing